S treptococcus pneumoniae is the most common bacterium isolated from adults with community-acquired meningitis and is responsible for the vast majority of deaths and/or neurologic sequelae (1-3). This particularly severe outcome may be the consequence of different events, such as cerebral herniation, decreased cerebral perfusion, extensive vasculitis, and neu-Simplified Acute Physiology Score II (odds ration [OR], 1.12; 95% confidence interval [CI], 1.072-1.153; p ‫؍‬ .002); isolation of a nonsusceptible strain (OR, 6.83; 95% CI, 2.94 -20.8; p < 10 ؊4 ), and an interval of >3 hrs between hospital admission and administration of antibiotics (OR, 14.12; 95% CI, 3.93-50.9; p < 10 ؊4 ). In contrast, a cerebrospinal fluid leukocyte count >10 3 cells/L had a protective effect (OR, 0.30; 95% CI, 0.10 -0.944; p ‫؍‬ 0.04).
ronal apoptosis (4) . Several previous studies, based on the analysis of large prospective (3) or retrospective (5, 6) cohorts, identified baseline factors associated with unfavorable outcome for patients with bacterial meningitis (5, 6) . However, data on prognostic factors in adults admitted to the intensive care unit (ICU) for S. pneumoniae meningitis are scarce or from a single institution (7) .
Prompt antibiotic treatment should be the standard of care for these patients.
However, although it has been suggested that delayed administration of antibiotics might be associated with unfavorable outcome (5, 8, 9) , to our knowledge, no study to date has clearly evaluated this association in the subset of patients with severe pneumococcal meningitis. In addition, a recent epidemiologic trend is the emergence of S. pneumoniae strains that are nonsusceptible to penicillin (PNSP) and cephalosporins. Because of poor penetration of antibiotics into the cerebrospinal fluid (CSF), a high minimal inhibitory concentration (MIC) could lead to clinical and/or microbiological failure. Consequently, therapy combining a ␤-lactam and vancomycin has become the standard for suspected pneumococcal meningitis. Therefore, the use of this optimal antibiotic regimen could explain why nonsusceptibility has not been found to be associated with a poorer Objective: To identify factors associated with mortality and morbidity among adults admitted to intensive care units (ICUs) for pneumococcal meningitis, particularly the impact of delayed antibiotic administration.
Design: We conducted a prospective, multicenter, observational study of 156 consecutive adults hospitalized for pneumococcal meningitis. We analyzed parameters associated with 3-month survival.
Setting: Fifty-six medical and medical-surgical ICUs in France. Intervention: None. Results: Of the 148 strains isolated, 56 (38%) were nonsusceptible to penicillin G. At 3 months after ICU admission, the mortality rate was 33% (51/156), and 34% of survivors (36/105) had neurologic sequelae. Multivariate analysis identified three variables as independently associated with 3-month mortality: outcome (7) . The objectives of this prospective multicenter study of adults admitted to ICUs for pneumococcal meningitis were to identify factors associated with 3-month mortality and morbidity, particularly the impact of delayed antibiotic administration.
METHODS
Among the 380 medical or medico-surgical French ICUs, 111 agreed to participate in the study, and 56 included at least one patient. From October 2001 to April 2003, all consecutive patients older than 18 yrs admitted to the ICU with community-acquired pneumococcal meningitis were prospectively evaluated. A standardized case-report form was completed by the physicians at participating centers for each episode. Patients were eligible if they had suspected meningitis, CSF pleocytosis (Ͼ10 cells/L), and one or more of the following criteria: a positive CSF or blood culture; Gram-positive diplococci in the CSF; and pneumococcal antigens in the CSF, detected by a latex agglutination method.
At hospital admission, we recorded each patient's age, sex, severity of underlying medical conditions (stratified according to the criteria of McCabe and Jackson (10)), signs, symptoms, and Glasgow Coma Scale (GCS) score (11); laboratory serum value; and CSF abnormalities, namely, glucose level, protein level, and leukocyte count. Conditions considered to be predisposing factors for meningitis included an immunocompromised state, proven or documented dural fistula, and chronic ear or sinus infection. Compromised immunity was defined as one of the following: human immunodeficiency virus (HIV) infection, malignancy not in remission, asplenia, diabetes mellitus, and long-term use of corticosteroids and/or other immunosuppressive medications. Dural fistula was considered probable when there was a history of head trauma or neurosurgery or a previous episode of pneumococcal meningitis or clinical CSF leak. At ICU admission, the following parameters were also determined: Simplified Acute Physiology Score (SAPS II) (12), GCS score, and the need for mechanical ventilation.
A 1-g oxacillin disk was used to identify penicillin-resistant strains. MICs for penicillin G, amoxicillin, and cefotaxime were determined in each hospital laboratory by means of the E test. Susceptibility categories were assigned according to the 1997 National Committee for Clinical Laboratory Standards guidelines for breakpoints: for penicillin G, Յ0.06 mg/L ϭ susceptible, 0.12-1 mg/L ϭ intermediate, and Ն2 mg/L ϭ resistant; for amoxicillin and cefotaxime, Յ0.5 mg/L ϭ susceptible, 1 mg/L ϭ intermediate, and Ն2 mg/L ϭ resistant (13) . For this analysis, any strain that was not fully susceptible to penicillin G (MIC, Ն0.12 mg/L) was considered to be nonsusceptible.
Initial antibiotic therapy was retrospectively defined as appropriate according to previous recommendations and MICs of ␤-lactamines against the strains (14) . Patients infected by a fully susceptible strain were considered to have received initial appropriate therapy if they had been treated with one of the following regimens: amoxicillin, Ն150 mg·kg·day; cefotaxime, Ն150 mg·kg·day; or ceftriaxone, Ն70 mg·kg·day (maximum, 4 g/day). For patients infected with nonsusceptible strains for which the cefotaxime MICs were Ͻ0.5 mg/L, the same drugs were considered adequate, but dosing should have been Ն200 mg·kg·day for amoxicillin or cefotaxime and Ն100 mg/kg for ceftriaxone. Finally, when the cefotaxime MIC was Ն0.5 mg/L, only patients who received a combination of cefotaxime or ceftriaxone (same dosages as above) and vancomycin (40 -60 mg·kg·day, after a loading dose of 15 mg/kg infused for 1 hr) or rifampin (600 -1200 mg/day) were considered to have been treated adequately.
The interval between hospital admission and antibiotic treatment was defined as the hours elapsed between the recorded time of hospital admission (i.e., when the patient first presented to the emergency department) and the time of the first administered dose of appropriate antibiotics. No standard therapeutic protocol was established, but the investigators were strongly encouraged to adhere to current antibiotic guidelines, to use appropriate treatment against cerebral edema when needed, and to prevent or treat seizures. Because the study was started before de Gans et al. (15) reported a beneficial effect of high-dose dexamethasone, adjunctive treatment with steroids was left to the physician's discretion.
Participating centers were asked to send isolated strains to the French National Reference Center for Pneumococci (CNRP; Hôpital Européen Georges Pompidou, Paris), where they were serotyped with use of latex particles sensitized with antisera purchased from the Statens Serum Institut (Copenhagen, Denmark). The panel of antisera used enabled recognition of the 90 known serotypes. Pneumococcal strains with known serotypes from the Statens Serum Institute and from the CNRP collection were used as internal quality controls.
Survival and neurologic impairment were assessed at hospital discharge and at 3 months after ICU admission. This assessment was made by the physician who was in charge of the patient during the ICU stay. Patients were considered to have neurologic sequelae if at least one of the following conditions was present: motor deficit, clinically detected hearing impairment, behavior or speech disturbance, and vegetative state. As proposed by other investigators (5) , an adverse clinical event was defined as death or neurologic impairment. In addition, the 3-month follow-up assessment included the Barthel Index Score (quantified in increments of 5), with 95 to 100 indicating functional independence; 55 to 90, moderate dependency; and 0 to 50, full dependency (16) .
The study was approved by the Commission d'Epidémiologie et de Recherche Clinique of the Société de Réanimation de Langue Française (SRLF), which provided funds in 2002 for study supplies (e.g., case-report forms). The study was approved by the ethics committee of the SRLF, which waived the requirement for written informed consent.
Statistical Methods. Results are expressed as numbers (percentages) for categorical variables and as mean (ϮSD) or median with 25th and 75th quartiles (Q1 and Q3) for continuous variables. Fisher's exact test and/or chi-square tests were used to compare categorical data and Wilcoxon's tests for continuous data. The relationship between 3-month outcome and collected variables was analyzed with a logistic regression model. The assumption that quantitative variables were linear in the logit was checked with use of cubic polynomials and graphic methods (17) . When this assumption was not verified, the variables were transformed into dummy variables based on their median value or on well-established cut-off values.
All variables that were clinically relevant or had a p value Ͻ.05 in the univariate analysis were entered into the logistic regression model. In order to cope with multicolinearity phenomena, severity score at admission and clinical and biological components of these scores at ICU admission were introduced alternatively into the model. We used the severity scores that minimized the Akaike information criterion (18) . A pooled test of all two-way interactions was performed on final models. Goodness-of-fit was evaluated with the Hosmer-Lemeshow statistic. All statistical tests were two-tailed, and p Ͻ .05 was considered significant. Statistical analyses were performed with use of the SAS software package (8.02; SAS, Cary, NC) for personal computers.
RESULTS
During the study period, a total of 156 consecutive episodes of pneumococcal meningitis among ICU patients were identified. During the same period, the estimated number of cases of pneumococcal meningitis in adults was 395 (0.83 cases per 100,000 habitants, per the Centre National de Référence des Pneumocoques).
The main characteristics were mean age of 56 Ϯ 17 yrs (range, 18 -90 yrs); male-tofemale ratio of 1.43; mean SAPS II of 46 Ϯ 23; and mean GCS scores of 10 Ϯ 3 and 9 Ϯ 3 at hospital and ICU admissions, respectively. One hundred twenty-nine patients were admitted directly from home or the emergency department. The remaining 27 patients were transferred from medical units in the same hospital or another hospital after a median of 25 hrs (Q1, Q3: 16.5, 66.2) of hospital stay. Every patient had clinical signs of meningitis at the time of hospital admission. No patient was admitted immediately after a head trauma or a neurosurgical intervention.
According to the McCabe and Jackson classification, 138 patients (88%) had no or nonfatal underlying disease, whereas 14 (9%) and 4 (3%) had ultimately fatal or rapidly fatal underlying disease, respectively. A total of 103 predisposing factors for invasive pneumococcal infection or pneumococcal meningitis were found in 82 patients (53%): an immunocompromised state in 41 (HIV infection, 9; asplenia, 5; malignancy or immunosuppressive therapy, 8; and diabetes mellitus, 19); documented or suspected dural fistula in 43; and coexisting otitis or sinusitis in 61 (39%).
A total of 110 patients (71%) required mechanical ventilation within 24 hrs of ICU admission. The mean systolic arterial pressure was 137 Ϯ 34 mm Hg, but 37 patients (24%) had septic shock caused by pneumococcal infection (mean arterial lactate concentration, 4.3 Ϯ 4.0 mmol/L). On presentation, 139 patients (89.1%) had altered consciousness, 29 (19%) had focal neurologic deficits, and 28 (18%) had generalized or focal seizures. Five patients (all with positive blood cultures) had definite concomitant S. pneumoniae endocarditis, with echocardiographically documented vegetation in all. S. pneumoniae was cultured in the CSF of 135 patients (87%) and in the blood of 105 patients (67%).
CSF direct examination was positive for 130 patients (83%). S. pneumoniae meningitis was diagnosed for eight patients on the basis of CSF Gram staining (n ϭ 5) or detection of pneumococcal antigens in the CSF (n ϭ 3). In only eight cases the diagnosis was based on the association of a positive blood culture and CSF pleocytosis. Among the 148 isolated strains, 56 (38%) were nonsusceptible to penicillin G. The MICs of amoxicillin were 0.5, 1, and 2 mg/L for 15, 20, and 2 strains, respectively. The MICs of cefotaxime were 0.5 and 1 mg/L for 10 and 20 strains, respectively, whereas for no strain was the cefotaxime MIC Ͼ1 mg/L. The first antimicrobial was administered before hospital admission in 15 cases (a median of 5.1 hrs before admission). Initial antibiotic treatment consisted of a third-generation cephalosporin for 53% of the episodes, a combination of third-generation cephalosporin and vancomycin for 29%, and amoxicillin for 18%. Among the 148 patients whose strain was isolated, initial antibiotic therapy was considered to be appropriate for 137 (93%): 47 of 56 (84%) with a PNSP strain and 90 of 92 (98%) with a fully susceptible strain. Nine regimens for patients infected with a PNSP were considered inappropriate for the following reasons: insufficient dosage, three patients; no coadministration of vancomycin, four; and administration of amoxicillin alone, two. The two inappropriate regimens for patients infected with a susceptible strains involved an insufficient dosage in both cases. The median time between the first clinical symptoms and the administration of the first antibiotic dose was 15 hrs (Q1, Q3: 7, 36), and the median interval between hospital admission and antibiotic treatment was 3 hrs (Q1, Q3: 1, 6). Patients whose initial treatment was inappropriate (antibiotic treatment delay Ͼ3 hrs) were similar to others according to age, sex, and comorbidities. They were less frequently referred directly from home (10 [ Adjunctive steroids were given to 65 patients (42%), but only 16 received corticosteroids concomitantly or within 30 mins of the first antibiotic dose. When computed tomography was performed before administration of the first dose of antimicrobials (n ϭ 34), the delay between hospital admission and the first dose of antimicrobials was significantly longer (2.5 hrs [Q1, Q3: 0, 3.5] vs. 3.1 hrs [Q1, Q3: 1, 7.25]; p ϭ .009).
The median ICU and hospital stays were 8.4 days (Q1, Q3: 4, 19) and 17 days (Q1, Q3: 11.5, 37), respectively. The in-ICU and 3-month mortality rates were 30% (47/156) and 33% (51/156), respectively. The Kaplan-Meier survival curve is shown in Figure 1 . Death occurred after a median time of 8.7 days (Q1, Q3: 2, 19), during the same hospitalization, for all four patients who died after ICU discharge. The median interval between ICU admission and death was 8.7 days (Q1, Q3: 2, 19.1). Sixteen patients died within the first 2 days of ICU admission, 24 between days 3 and 15, 7 between days 16 and 30, and 4 after day 30. The causes of death were analyzed prospectively by the intensivists and were septic shock in 10 cases, brain death in 14 cases, and multiple organ failure due to the pneumococcal disease in 12 cases. Death was consid- ered to be due to comorbidities, nosocomial infections, or iatrogenic events in the remaining cases. At the 3-month follow-up, 69 of the 105 survivors (66%) had no neurologic disability. The 45 sequelae identified in the 36 remaining patients were isolated hearing loss (n ϭ 14), behavior disturbances (n ϭ 10), hemiparesis (n ϭ 9), speech disturbances (n ϭ 8), and a vegetative state (n ϭ 4). The mean Barthel Index Score for the 105 survivors at 3 months was 87 Ϯ 30, with 79%, 8.5%, and 12.5% of survivors being, respectively, functionally independent (score of 95-100), moderately dependent (55-90), and fully dependent (0 -50).
Univariate analysis of the relationship between baseline characteristics and 3-month mortality is reported in Table 1 . Nonsurvivors were significantly older, had a higher median SAPS II (p Ͻ 10 Ϫ4 ), a lower median GCS score (p ϭ .002), and less frequent concomitant sinusitis or otitis and more frequently required mechanical ventilation (p ϭ .002) than survivors. Survivors and nonsurvivors did not differ significantly with respect to CSF characteristics, except for a leukocyte count Ͼ1000 cells/L, which was observed more frequently in survivors. In addition, nonsurvivors were more often infected with a PNSP (p ϭ .02) and had a longer median interval between hospital admission and antibiotic treatment (median, 6 hrs [Q1, Q3: 3, 9] vs. 2 hrs [Q1, Q3: 0.9, 4]; p Ͻ 10 Ϫ4 ). In contrast, a trend toward more frequent administration of adjuvant corticosteroid to patients who did not survive was observed. Although differences with patients not given corticosteroids did not reach statistical significance, patients who received corticosteroids tended to be slightly older (57 Ϯ 18 vs. 55 Ϯ 16 yrs; p ϭ .28), to have a higher SAPS II (48 Ϯ 21 vs. 45 Ϯ 23; p ϭ .4), and to receive more frequently inotropic support at ICU admission (39% vs. 26%; p ϭ .13). Moreover, they more frequently had an admissionto-antibiotics interval Ͼ3 hrs (39% vs. 56%; p ϭ .04).
Multivariate analysis identified only three variables independently associated with 3-month mortality: SAPS II, recovery of a PNSP isolate, and an interval between admission and antibiotic treatment Ͼ3 hrs, which was the strongest indicator of mortality, with an odds ratio of 14.12. In contrast, a CSF leukocyte count Ͼ10 3 /mL had a protective effect ( Table 2) .
Univariate and multivariate analyses of the relationship between baseline characteristics and adverse clinical events noted at the 3-month assessment are shown in Tables 3 and 4 , respectively. Again, the isolation of a PNSP strain, SAPS II, and an admission-to-antibiotics interval Ͼ3 hrs were independently associated with adverse clinical events. Corticosteroid use did not differ significantly among survivors with no adverse clinical events at 3 months (25/69, or 36%) in comparison with patients who had adverse events (40/87, or 46%; p ϭ .22). Pertinently, steroids were administered within 30 mins of the first antibiotic dose to 11 of 69 patients (16%) with favorable outcomes, vs. only 5 of 87 patients (6%) with an adverse clinical event (p ϭ .04). Pneumococcal serotypes were available for 111 (75%) of the 148 isolated strains. The number of PNSP and the correlation of outcome to serotypes is reported in Table 5 . The initial coadministration of 
DISCUSSION
Herein we analyzed the largest prospectively studied cohort to date of adults with community-acquired pneumococcal meningitis necessitating ICU admission. In agreement with findings in the most recent studies (3, 7) , mortality and mor-bidity rates were high, with 33% of the patients having died by 3 months after ICU admission and only 44% surviving without any neurologic sequelae.
The most relevant prognostic factor identified by our multivariate model was a delay (Ͼ3 hrs) in antibiotic administration. Standard reference sources and the most recently published guidelines have recommended that patients with purulent meningitis be given the first antibiotic dose as soon as possible, even before CSF has been drawn via lumbar puncture (19) . Unfortunately, as previously reported, a substantial proportion of patients with suspected bacterial meningitis receive the first antibiotic dose several hours after their arrival in the emergency department (20) . In a previous study of 269 adults with community-acquired meningitis, late initiation of therapy after emergency department admission was associated with a poor outcome when the patient's condition had already advanced to the highest stage of prognostic severity before the first antibiotic dose was administered (5) . In contrast, no relationship between outcome and antibiotic timing was found in another retrospective study, of 93 children with bacterial meningitis (21) .
A recently published retrospective cohort study of 123 adults with bacterial meningitis found that an interval between hospital admission and antibiotic treatment of Ͼ6 hrs was significantly associated with death. Factors associated with delayed antibiotic administration were transfer from other institutions and the diagnosis-treatment sequence of computed tomography followed by lumbar puncture and, finally, antibiotic dosing (9) .
Neck stiffness was reported at the initial presentation of 112 of 156 patients, according to the information recorded in interviews of either proxies or patients without altered consciousness, and in 116 of 156 cases at ICU admission. This finding is quite similar to that observed in a study in the Netherlands (3). Other elements of the classic triad (fever and altered consciousness) are too unspecific in the setting of critically ill patients requiring ICU admission. Initial atypical presentation was associated in the univariate analysis with poor outcome and with delayed antibiotic therapy. This finding emphasizes the need for immediate antibiotic therapy, before cerebral imaging (22) , even if symptoms are atypical and bacterial meningitis is only slightly suspected.
Our results confirmed the importance of antibiotic timing in a more homogeneous population of critically ill adults with S. pneumoniae meningitis. In contrast to previous studies that assessed this issue, our study was prospective and multicentric and all characteristics of antibiotics administered, such as dosage and route, had been recorded. This impact of late treatment initiation is of crucial importance in view of the fact that thera- (14) .49 SAPS II, median (Q1, Q3) 34 (25, 43) 53 (41, 74) Ͻ10 Ϫ4 Prior hospitalization, within 6 mos (%) 7 (10) 18 (21) .08 Prior antibiotic treatment, within 6 mos (%) 14 (20) 22 (25) .46 GCS, median (Q1, Q3) 9 (7, 13) 8 (6, 11) .02 Mechanical ventilation (%) 36 Table 3 were introduced in the model at the first step of a stepwise selection procedure. a Per point.
peutic parameters are the only factors that can be modified by the physician in the emergency department. We also found that patients infected with PNSP had poorer outcomes, in terms of both mortality and adverse events at 3 months. The influence of penicillin resistance on the outcome of severe pneumococcal disease is still controversial. A recent prospective, international, observational study of 844 hospitalized patients with pneumococcal bacteremia failed to identify penicillin nonsusceptibility as a risk factor for mortality, but patients with meningitis were excluded from that analysis (23) . This lack of association between ␤-lactam susceptibility and outcome was also found in several previous studies of adults or children with pneumococcal meningitis, including critically ill patients hospitalized in an ICU (7, 24 -26) .
Our unexpected finding of a relationship between antibiotic resistance and outcome merits further examination. One explanation could have been that patients infected with PNSP had more fre-quently received treatment with inappropriate antibiotic regimens. However, this explanation is unlikely because the vast majority (92%) of the patients in our cohort were treated according to published guidelines, with no significant difference between patients infected by susceptible and PNSP strains. A subgroup analysis involving only appropriately treated patients showed a similar independent relationship between PNSP strains and mortality (data not shown). However, we cannot exclude that even recommended combinations could have an insufficient bactericidal effect against some PNSP strains (27) .
A second explanation could be linked to the intrinsic virulence of strains. The results of previous studies suggested that serotype-specific characteristics of pneumococci might play a major role in the inflammatory processes in experimental meningitis and that each strain might behave differently (28 -30) . However, we did not find major differences in the 3-month outcome in association with different serotypes ( Table 5) .
Using a murine peritonitis model, we previously failed to identify any strain that was both virulent and PNSP, thereby suggesting a possible relationship between simultaneous acquisition of penicillin resistance and loss of virulence in S. pneumoniae (31) . However, the same team subsequently showed that compensatory mutations were implicated in the revival of virulence (32) . Hence, this adaptive process might explain the enhanced involvement of PNSP in human bacteremia (33) . Our finding that patients infected with a PNSP strain had poorer outcomes would seem to suggest either that these strains are more virulent than fully susceptible ones or that their eradication may be delayed. Only further experimental studies will be able to confirm or refute these hypotheses.
Apart from SAPS II, which reflects disease severity at ICU admission, the last factor associated with outcome was a CSF leukocyte count Ͼ10 3 /mL. In agreement with the results of a recently published cohort study of adults with bacterial meningitis (3) and with those of previous investigations (34, 35) , we found that a low count was associated with an adverse event. Although leukocytes are powerful effectors of tissue damage in bacterial meningitis (36) , the lack of leukocyte response in the CSF may also be harmful (37) .
Finally, corticosteroids were not associated with improved prognosis in our population, in contrast to the results of a randomized, double-blind study (15, 38) . However, our investigation was not controlled, and as observed in a recent prospective cohort study of adults with bacterial meningitis (3), patients who received corticosteroids had a more severe disease at baseline than those not treated with steroids.
Our study has several important limitations. Although most patients received appropriate initial antibiotic treatment, because of the high number of participating centers, no standardized protocol has been established for supportive and specific therapies, especially those used to reduce intracranial pressure. We also did not evaluate factors associated with delayed antibiotic administration, such as the role of computed tomography of the head, which has been shown to prolong the interval between hospital admission and lumbar puncture (39) .
The serotypes 19A, 6B, 14, 18C, 9V, and 3 were the strains most frequently isolated. This finding corresponds to the most frequent serotypes recovered from CSF during the study period by the national reference center for pneumococci and is comparable to those observed in the Dutch survey (3). Because serotypes were available for only 71% of the patients and because there were only a few patients in each serotype group, this variable was not introduced in the multivariate analysis. Finally, the clinical evaluations of patients were conducted by different physicians at hospital discharge and at 3 months after ICU admission. We cannot exclude the possibility that examination by a neurologist could have resulted in some differences with regard to suspicion of an adverse event. Moreover, the 3-month follow-up assessment did not include audiometric or psychometric tests.
In conclusion, we identified an interval of Ͼ3 hrs between the time of hospital admission and administration of antibiotics as the strongest indicator of 3-month mortality for patients with pneumococcal meningitis. We therefore confirm that bacterial meningitis is a neurologic emergency that requires the administration of appropriate antibiotics as soon as the diagnosis is suspected. Contrary to previous findings, nonsusceptibility to penicillin G was associated with a poorer outcome. This finding could not be explained by a higher percentage of inappropriate antibiotic treatment of patients infected with PNSP. Whether this result ; c other serotypes (number of patients): 1 (2), 4(1), 9N (2), 10A (2), 15B (1), 15C (1), 17 F(1), 20 (1), 23A (1), 24F (2), 29 (1), 34 (1), 35 (1), 38 (2), and nontypeable (1). reflects a higher virulence of PNSP strains or less bactericidal activity of antibiotics against such strains remains to be investigated.
